Atlas Trials

Long-term Safety and Tolerability of Atacicept (Long-term Follow-Up of Participant Who Participated in ADDRESS II)

Clinical trial NCT02070978 · TERMINATED

Trial details

NCT number
NCT02070978
Sponsor
EMD Serono
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Lupus Erythematosus, Systemic
Start date
2014-07-29
Primary completion
2016-04-05
Enrollment
253

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.